Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The investigators will conduct a randomized controlled trial comparing the use of nasal
midazolam, using a Mucosal Atomization Devise, to rectal diazepam for the treatment of acute
seizure activity in children under the age of 18 years with epilepsy in the community
setting. The primary hypothesis is that nasal midazolam will be more effective and have
shorter seizure time compared to rectal diazepam in the community. The secondary hypotheses
are that patients treated with nasal midazolam will have fewer respiratory complications,
emergency department visits, and admissions.